Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Clinical trial NCT04755283 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04755283
- Sponsor
- Anthos Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-02
- Primary completion
- 2024-02-15
- Enrollment
- 1287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.